MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

866.626.6847

Buspirone (Buspar®)

Selected References:

  • Brent B, Wisner K. 1998. Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair. Clin Pediatr; 37:41-4.
  • Burdine J, Luedtke S. 2021. Serotonin Toxicity Versus Withdrawal: Clonidine One Size Fits All? The journal of pediatric pharmacology and therapeutics: JPPT: the official journal of PPAG ;26(5):502-17.
  • Freeman MP, et al. 2022. Pregnancy outcomes after first-trimester exposure to buspirone: prospective longitudinal outcomes from the MGH National Pregnancy Registry for Psychiatric Medications. Arch Women’s Mental Health ;25(5):923-928.
  • Meltzer HY et al. 1983. The effect of buspirone on prolactin and growth hormone secretion in man. Arch Gen Psychiatry 40:1099-102.
  • Newport D, Ritchie J, Knight B, et al. 2009. Venlafaxine in human breast milk and nursing infant plasma: Determination of exposure. J Clin Psychiatry ;70:1304-10.

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.